Last Updated
11 March 2021

ADPD: Proteograph Profiling of Alzheimer’s and Mild Cognitive Impairment Highlights Candidate Biomarkers

John Blume, Ph.D., discusses how the Proteograph Product Suite can be used to identify novel and known candidate biomarkers in Alzheimers and Mild Cognitive Impairment (MCI)